Abstract
GH hyperproduction due to ectopic secretion of GHRH is a rare cause of acromegaly. Since 1959, approximately 50 cases of ectopic GHRH production from extrapituitary tumors have been described. Here we report the clinical and biochemical features of a 47-yr-old Caucasian woman with ectopic GHRH syndrome sustained by a bronchial carcinoid. The criteria for the diagnosis of acromegaly due to ectopic GHRH secretion were satisfied in our patient (i.e. confirmation of active GH hypersecretion, unequivocal demonstration of GHRH production and secretion from an extrapituitary tumor and cure of acromegaly after neoplasm removal). The tumor was an atypical carcinoid and there was a familial history of lung and colorectal cancer. Acromegaly was slightly active (mean GH value: 7.4 ng/ml, IGF-I: 436 ng/ml) and after tumor removal there was a progressive decline of GH levels, consistent with remission of pituitary somatotroph hyperplasia. Pituitary radiology showed an empty sella demonstrating for the first time its association with ectopic GHRH syndrome.
Similar content being viewed by others
References
Faglia G., Arosio M., Bazzoni N. Ectopic acromegaly. Mndocrinol. Metab. Clin. North. Am. 1992, 21: 575–595.
Altmann H.W., Schütz W. Über ein Knochenhaltiges Bronchuscarcinoid (Morphologische und Klinische Beobachtungen bei einer akromegalen Patientin). Beitr. Pathol. Anat. 1959, 120: 455.
Buse J., Buse M.G., Roberts W.J. Jr. Eosinophilic adenoma of the pituitary and carcinoid tumour of the rectosigmoid area. J. Clin. Endocrinol. Metab. 1961, 21: 735–738.
Dabek J.T. Bronchial carcinoid tumour with acromegaly in two patients. J. Clin. Endocrinol. Metab. 1974, 38: 329–333.
Sönsken P.H., Ayres A.B., Braimbridge M. et al. Acromegaly caused by pulmonary carcinoid tumours. Clin. Endocrinol. 1976, 5: 503–513.
Rivier J., Spiess J., Thorner M.O., Vale W. Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour. Nature 1982, 300: 276–278.
Guillemin R., Brazeau P., Bolhen P. et al. Growth hormonereleasing factor from a human pancreatic tumour that caused acromegaly. Science 1985, 218: 585.
Ling N., Esch F., Böhlen P., Brazeau P., Wehrenberg W.B., Guillemin R. Isolation, primary structure, and synthesis of human hypothalamic somatocrinin: Growth hormone-releasing factor. Proc. Natl. Acad. Sci. USA. 1984, 81: 4302–4306.
Melmed S., Ezrin C., Kovacs K., Goodman R.S., Frohman L.A. Acromegaly due to secretion of growth hormone by an ectopic pancreatic islet-cell tumour. N. Engl. J. Med. 1985, 312: 9–17.
Beuschlein F., Strasburger C.J., Siegerstetter V., Moradpour D., Lichter P., Bidlingmaier M. Acromegaly caused by secretion of growth hormone by a non Hodgkin’s lymphoma. N. Engl. J. Med. 2000, 22: 1871–1876
Van den Bruel A., Fevery J., Van Dorpe J., Hofland L., Bouillon R. Hormonal and volumetric long term control of growth hormone-releasing hormone-producing carcinoid tumour. J. Clin. Endocrinol. Metab. 1999, 84: 3162–3169.
Furrer J., Hattenschwiler A., Komminoth P., Pfammatter T., Wiesli P. Carcinoid syndrome, acromegaly and hypoglicemia due to insulin-secreting neuroendocrine tumor of the liver. J. Clin. Endocrinol. Metab. 2001, 86: 2227–2230.
Othman N.H., Ezzat S., Kovacs K. et al. Growth hormonereleasing hormone (GHRH) and GHRH receptor (GHRH-R) isoform expression in ectopic acromegaly. Clin. Endocrinol. 2001, 55: 135–140
Asa S.L. Kovacs K., Thorner M.O., Leong D.A., Rivier J., Vale W. Immunohistological localization of growth hormone- releasing hormone in human tumours. J. Clin. Endocrinol. Metab. 1985, 60: 423–427.
Volante M., Pecchioni C., Bussolati G. Post-incubation heating significantly improves tyramide signal amplification. J. Histochem. Cytochem. 2000, 48: 1583–1585.
Losa M., Von Werder K. Pathophysiology and clinical aspects of the ectopic GH-releasing hormone syndrome. Clin. Endocrinol. 1997, 47: 123–135.
Melmed S., Jackson I., Kleinberg D., Klibanski A. Current treatment guidelines for acromegaly. J. Clin. Endocrinol. Metab. 1998, 83: 2646–2652.
Giustina A., Barkan A., Casanueva F.F., Cavagnini F., Frohman L., Ho K. Criteria for cure of acromegaly: a consensus statement. J. Clin. Endocrinol. Metab. 2000, 85: 526–529.
Nobels F.R.E., Kwekkeboom D.J., Bouillon R., Lamberts S.W.J. Chromogranin A: its clinical value as marker of neuroendocrine tumours. Eur. J. Clin. Invest. 1998, 28: 431–440.
Stivanello M., Berruti A., Torta M., Termine A., Tampellini M., Gorzegno G. Circulating Chromogranin A in the assessment of patients with neuroendocrine tumours. A single Institution experience. Ann. of Oncol. 2001, 12: S73–S77.
Doga M., Bonadonna S., Burattin A., Giustina A. Ectopic secretion of growth hormone-releasing hormone (GHRH) in neuroendocrine tumors: relevant clinical aspect. Ann. Oncol. 2001, 12: S89–S94.
Sano T., Asa S.L., Kovacs K. Growth hormone-releasing hormone- producing tumours: clinical, biochemical, and morphological manifestations. Endocr. Rev. 1988, 9: 357–373.
Santeusanio F., Editorial. GH and primary empty sella. J. Endocrinol. Invest. 2002, 25: 574–575.
Yamada S., Aiba T., Takada K. et al. Retrospective analysis of long-term surgical results in acromegaly: preoperative an postoperative factors predicting outcome. Clin. Endocrinol. 1996, 45: 291–298.
Krenning E.P., Kwekkeboom D.J., Reubi J.C. et al. 111Inoctrotide scintigraphy in oncology. Metabolism 1992, 41: 83–86.
Platts J.K., Child D.F., Meadows P., Harvey J.N. Ectopic acromegaly. Postgrad. Med. J. 1996, 73: 349–351.
Jansson J.O., Svensson J., Bengtsson B.A. et al. Acromegaly and Cushing’s syndrome due to ectopic production of GHRH and ACTH by a thymic carcinoid tumour: in vitro responses to GHRH and GHRP-6. Clin. Endocrinol. (Oxf.) 1998, 48: 243–250.
Drange M.R., Melmed S. Long-acting lanreotide induces clinical and biochemical remission of acromegaly caused by disseminated growth hormone-releasing hormone-secreting carcinoid. J. Clin. Endocrinol. Metab. 1998, 83: 3104–3109.
Hofland L.J., Lamberts S.W.J. Somatostatin receptor subtype expression in human tumors. Ann. Oncol. 2001, 12: S31–S36.
Papotti M., Croce S., Bello M., Bongiovanni M. et al. Expression of somatostatin receptor types 2-3 and 5 in biopses and surgical specimens of human lung tumors. Correlation with preoperative octreotide scintigraphy. Virchows Arch. 2001, 439: 787–797.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Osella, G., Orlandi, F., Caraci, P. et al. Acromegaly due to ectopic secretion of GHRH by bronchial carcinoid in a patient with empty sella. J Endocrinol Invest 26, 163–169 (2003). https://doi.org/10.1007/BF03345146
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03345146